DICE Therapeutics
DICE
$47.55
Share price
0.00%
Change (1 day)
176.78%
Change (1 year)
Categories
DICE Therapeutics (DICE) - Cash on Hand
Cash on Hand as of June 2023 : $0.52 B
According to DICE Therapeutics's latest financial reports the company has $0.52 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
DICE Therapeutics - Cash on Hand chart (from 2020 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.57 B | 79.83% |
| 2021-12-31 | $0.31 B | 434.99% |
| 2020-12-31 | $59.68 M | 124.16% |
| 2019-12-31 | $26.62 M |